Publicaciones en las que colabora con Jaime Feliu Batlle (13)

2023

  1. ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA

    Genome Medicine, Vol. 15, Núm. 1

  2. Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402

    Journal of the National Cancer Institute, Vol. 115, Núm. 12, pp. 1497-1505

2021

  1. Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab

    Scientific Reports, Vol. 11, Núm. 1

  2. SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)

    Clinical and Translational Oncology, Vol. 23, Núm. 5, pp. 988-1000

2020

  1. Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell Carcinoma

    Translational Oncology, Vol. 13, Núm. 7

  2. Genetic profile and functional proteomics of anal squamous cell carcinoma: Proposal for a molecular classification

    Molecular and Cellular Proteomics, Vol. 19, Núm. 4, pp. 690-700

  3. VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02)

    Cancer Medicine, Vol. 9, Núm. 3, pp. 1008-1016

2019

  1. Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer

    ESMO Open, Vol. 4, Núm. 4

2016

  1. Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?

    Clinical and Translational Oncology, Vol. 18, Núm. 11, pp. 1072-1081

2014

  1. Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer

    Clinical and Translational Oncology, Vol. 16, Núm. 11, pp. 942-953

  2. Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma

    Cancer

2013

  1. SEOM Clinical guidelines for the treatment of advanced colorectal cancer 2013

    Clinical and Translational Oncology, Vol. 15, Núm. 12, pp. 996-1003

2011

  1. Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain

    Clinical and Translational Oncology, Vol. 13, Núm. 11, pp. 798-804